vs
Side-by-side financial comparison of Mativ Holdings, Inc. (MATV) and Bio-Techne (TECH). Click either name above to swap in a different company.
Mativ Holdings, Inc. is the larger business by last-quarter revenue ($463.1M vs $295.9M, roughly 1.6× Bio-Techne). Mativ Holdings, Inc. runs the higher net margin — 21.8% vs 12.8%, a 8.9% gap on every dollar of revenue. On growth, Mativ Holdings, Inc. posted the faster year-over-year revenue change (1.0% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -3.8%).
Mativ Holdings, Inc. is a global specialty materials manufacturer producing high-performance advanced polymers, nonwovens, filtration solutions, and functional coated materials. It serves healthcare, industrial, consumer goods, aerospace, and energy segments, with operations across North America, Europe, and Asia Pacific.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
MATV vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $463.1M | $295.9M |
| Net Profit | $100.8M | $38.0M |
| Gross Margin | 18.8% | 64.6% |
| Operating Margin | 2.2% | 18.4% |
| Net Margin | 21.8% | 12.8% |
| Revenue YoY | 1.0% | -6.4% |
| Net Profit YoY | 6620.0% | 68.3% |
| EPS (diluted) | $1.87 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $463.1M | $295.9M | ||
| Q3 25 | $513.7M | — | ||
| Q2 25 | $525.4M | $317.0M | ||
| Q1 25 | $484.8M | $316.2M | ||
| Q4 24 | $458.6M | $297.0M | ||
| Q3 24 | $498.5M | $289.5M | ||
| Q2 24 | $523.8M | $306.1M | ||
| Q1 24 | $500.2M | $303.4M |
| Q4 25 | $100.8M | $38.0M | ||
| Q3 25 | $-3.2M | — | ||
| Q2 25 | $-9.5M | $-17.7M | ||
| Q1 25 | $-425.5M | $22.6M | ||
| Q4 24 | $1.5M | $34.9M | ||
| Q3 24 | $-20.8M | $33.6M | ||
| Q2 24 | $-1.4M | $40.6M | ||
| Q1 24 | $-28.0M | $49.1M |
| Q4 25 | 18.8% | 64.6% | ||
| Q3 25 | 19.3% | — | ||
| Q2 25 | 19.7% | 62.7% | ||
| Q1 25 | 15.0% | 67.9% | ||
| Q4 24 | 16.9% | 65.3% | ||
| Q3 24 | 18.8% | 63.2% | ||
| Q2 24 | 20.8% | 66.4% | ||
| Q1 24 | 16.8% | 67.4% |
| Q4 25 | 2.2% | 18.4% | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 3.8% | -7.5% | ||
| Q1 25 | -88.8% | 12.2% | ||
| Q4 24 | 0.6% | 16.0% | ||
| Q3 24 | 1.4% | 13.8% | ||
| Q2 24 | 2.0% | 15.0% | ||
| Q1 24 | -2.8% | 22.1% |
| Q4 25 | 21.8% | 12.8% | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | -1.8% | -5.6% | ||
| Q1 25 | -87.8% | 7.1% | ||
| Q4 24 | 0.3% | 11.7% | ||
| Q3 24 | -4.2% | 11.6% | ||
| Q2 24 | -0.3% | 13.3% | ||
| Q1 24 | -5.6% | 16.2% |
| Q4 25 | $1.87 | $0.24 | ||
| Q3 25 | $-0.06 | — | ||
| Q2 25 | $-0.18 | $-0.11 | ||
| Q1 25 | $-7.82 | $0.14 | ||
| Q4 24 | $0.03 | $0.22 | ||
| Q3 24 | $-0.38 | $0.21 | ||
| Q2 24 | $-0.03 | $0.26 | ||
| Q1 24 | $-0.52 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.2M | $172.9M |
| Total DebtLower is stronger | $1.0B | $260.0M |
| Stockholders' EquityBook value | $498.7M | $2.0B |
| Total Assets | $2.1B | $2.5B |
| Debt / EquityLower = less leverage | 2.07× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.2M | $172.9M | ||
| Q3 25 | $97.1M | — | ||
| Q2 25 | $95.6M | $162.2M | ||
| Q1 25 | $84.0M | $140.7M | ||
| Q4 24 | $94.3M | $177.5M | ||
| Q3 24 | $162.2M | $187.5M | ||
| Q2 24 | $133.4M | $152.9M | ||
| Q1 24 | $128.9M | $145.3M |
| Q4 25 | $1.0B | $260.0M | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | $346.0M | ||
| Q1 25 | $1.1B | $330.0M | ||
| Q4 24 | $1.1B | $300.0M | ||
| Q3 24 | $1.2B | $300.0M | ||
| Q2 24 | $1.2B | $319.0M | ||
| Q1 24 | $1.2B | $389.0M |
| Q4 25 | $498.7M | $2.0B | ||
| Q3 25 | $397.4M | — | ||
| Q2 25 | $416.6M | $1.9B | ||
| Q1 25 | $428.2M | $2.0B | ||
| Q4 24 | $858.5M | $2.1B | ||
| Q3 24 | $882.3M | $2.1B | ||
| Q2 24 | $898.0M | $2.1B | ||
| Q1 24 | $906.9M | $2.0B |
| Q4 25 | $2.1B | $2.5B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.1B | $2.6B | ||
| Q4 24 | $2.4B | $2.7B | ||
| Q3 24 | $2.6B | $2.7B | ||
| Q2 24 | $2.6B | $2.7B | ||
| Q1 24 | $2.7B | $2.7B |
| Q4 25 | 2.07× | 0.13× | ||
| Q3 25 | 2.63× | — | ||
| Q2 25 | 2.66× | 0.18× | ||
| Q1 25 | 2.67× | 0.16× | ||
| Q4 24 | 1.30× | 0.14× | ||
| Q3 24 | 1.32× | 0.14× | ||
| Q2 24 | 1.29× | 0.15× | ||
| Q1 24 | 1.30× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | — |
| Free Cash FlowOCF − Capex | $8.0M | — |
| FCF MarginFCF / Revenue | 1.7% | — |
| Capex IntensityCapex / Revenue | 2.4% | — |
| Cash ConversionOCF / Net Profit | 0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $93.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | — | ||
| Q3 25 | $72.8M | — | ||
| Q2 25 | $57.6M | $98.2M | ||
| Q1 25 | $-15.9M | $41.1M | ||
| Q4 24 | $24.1M | $84.3M | ||
| Q3 24 | $37.6M | $63.9M | ||
| Q2 24 | $46.1M | $75.5M | ||
| Q1 24 | $-13.0M | $81.0M |
| Q4 25 | $8.0M | — | ||
| Q3 25 | $66.7M | — | ||
| Q2 25 | $48.9M | $93.3M | ||
| Q1 25 | $-29.8M | $31.0M | ||
| Q4 24 | $2.0M | $77.5M | ||
| Q3 24 | $25.5M | $54.7M | ||
| Q2 24 | $37.4M | $57.5M | ||
| Q1 24 | $-25.1M | $64.5M |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | 9.3% | 29.4% | ||
| Q1 25 | -6.1% | 9.8% | ||
| Q4 24 | 0.4% | 26.1% | ||
| Q3 24 | 5.1% | 18.9% | ||
| Q2 24 | 7.1% | 18.8% | ||
| Q1 24 | -5.0% | 21.3% |
| Q4 25 | 2.4% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.7% | 1.5% | ||
| Q1 25 | 2.9% | 3.2% | ||
| Q4 24 | 4.8% | 2.3% | ||
| Q3 24 | 2.4% | 3.2% | ||
| Q2 24 | 1.7% | 5.9% | ||
| Q1 24 | 2.4% | 5.4% |
| Q4 25 | 0.19× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | 16.07× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
